Amgen's Imdelltra with AstraZeneca's Imfinzi improves survival in late-stage small-cell lung cancer trial

SentiSense · Published · Updated

AMGN and AstraZeneca said on September 8, 2026 that combining AstraZeneca's Imfinzi with Amgen's Imdelltra significantly improved over...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis